Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Expert Answers to HCP Questions on Pancreatic Cancer Treatment

Listen to experts answer audience questions from a live CCO webinar focused on current best practices and emerging strategies in treating patients with resectable and advanced pancreatic cancer.
Michael J. Pishvaian, MD, PhD
Rachna Shroff, MD
Released: March 22, 2021

In this episode, Michael J. Pishvaian, MD, PhD, and Rachna Shroff, MD, answer audience questions from a live CCO webinar focused on current best practices and emerging strategies in pancreatic cancer treatment, with questions including:

  • What is your preferred regimen for neoadjuvant therapy in patients with resectable disease?
  • How do you sequence therapy for patients with metastatic pancreatic cancer?
  • How can you manage a patient who develops significant diarrhea with FOLFIRINOX?
  • Are cisplatin and oxaliplatin equally efficacious for patients with BRCA-mutant disease?
  • How should maintenance olaparib be used?

Presenters:

Michael J. Pishvaian, MD, PhD  
Associate Professor of Oncology
Director, Gastrointestinal, Developmental Therapeutics, and Clinical Research Programs
NCR Kimmel Cancer Center at Sibley Memorial Hospital
John Hopkins University School of Medicine
Washington, DC

Rachna Shroff, MD
Associate Professor of Medicine
Chief, Section of GI Medical Oncology
Director, UACC Clinical Trials Office
The University of Arizona Cancer Center
Tucson, Arizona

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Bristol-Myers Squibb
Ipsen Biopharmaceuticals, Inc.

Related Content

Experts highlight key studies being presented at the upcoming 2021 ESMO Congress in this commentary from Clinical Care Options (CCO)

person default Eva Ciruelos, MD, PhD Karim Fizazi, MD, PhD Eric Van Cutsem, MD, PhD person default Vamsidhar Velcheti, MD Released: September 15, 2021

Enter the characteristics of your patients with pancreatic cancer into this online tool from Clinical Care Options (CCO) to receive expert treatment recommendations

Andrew H. Ko, MD
Program Director
Elena Gabriela Chiorean, MD Dan Laheru, MD person default Paul E. Oberstein, MD Michael J. Pishvaian, MD, PhD
Released: September 13, 2021

Listen as John Marshall, MD, discusses molecular testing in gastrointestinal cancers in a podcast from Clinical Care Options (CCO)

John L. Marshall, MD Released: August 18, 2021

From Clinical Care Options (CCO), download a PDF featuring expert discussion of biomarkers in gastrointestinal cancers

John L. Marshall, MD Released: August 18, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue